INM Stock Summary and Trading Ideas (Inmed Pharmaceuticals - Common Shares | NASDAQ:INM)

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Inmed Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol INM.

As of July 10, 2026, INM stock price declined to $1.64 with 9,578 million shares trading.

INM has a beta of 2.32, meaning it tends to be more sensitive to market movements. INM has a correlation of 0.05 to the broad based SPY ETF.

INM has a market cap of $8.76 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, INM traded as high as $41.60 and as low as $.58.

INM has underperformed the market in the last year with a return of -41.8%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INM shares. However, INM has outperformed the market in the last 3 month and 2 week periods, returning +129.2% and +6.5%, while SPY returned +11.4% and +3.6%, respectively. This indicates INM has been having a stronger performance recently.

INM support price is $1.59 and resistance is $1.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INM shares will trade within this expected range on the day.